Aura Biosciences, Inc. (AURA)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 7.49 |
| Open | 7.38 |
| Bid | 7.38 x 200 |
| Ask | 7.44 x 100 |
| Day's range | 7.34 - 7.48 |
| 52-week range | 5.99 - 13.50 |
| Volume | |
| Avg. volume | 182,919 |
| Market cap | 366.049M |
| Beta (5Y monthly) | 0.35 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.93 |
| Earnings date | 09 May 2024 - 10 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 19.80 |
GlobeNewswireAura Biosciences to Participate in Upcoming Investor Conferences
BOSTON, May 08, 2024 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing precision immunotherapies to treat solid tumors designed to preserve the function of the organ with cancer, today announced that Elisabet de los Pinos, PhD, Chief Executive Officer, will participate in the following upcoming investor conferences: The Citizens JMP Life Sciences Conference on Monday, May 13, 2024.Fireside Chat at 9:00 a.m. ET. TD Cowen 5th Annual Oncolo
Simply Wall St.One Aura Biosciences Insider Raised Stake By 232% In Previous Year
Insiders were net buyers of Aura Biosciences, Inc.'s ( NASDAQ:AURA ) stock during the past year. That is, insiders...
- Simply Wall St.
We're Not Very Worried About Aura Biosciences' (NASDAQ:AURA) Cash Burn Rate
We can readily understand why investors are attracted to unprofitable companies. For example, although...
© 2024 Yahoo. All rights reserved.